References
- YangJJHuZGShiWXDengTHeSQYuanSGPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisWorld J Gastroenterol20152192807281525759553
- HamHKimSGKwonHJHaHChoiYYDistal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axisAnn Surg Treat Res201589416717526446424
- TorgesonAGarrido-LagunaITaoRCannonGMScaifeCLLloydSValue of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive marginsESMO Open201831e00028229387477
- DengLCaiXShengDA Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal TherapyTheranostics20177184410442329158836
- ChenXZhouHLiXPlectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer ImagingEBioMedicine20183012913729574092
- ZhangRLiuYHammacheKThe role of FADD in pancreatic cancer cell proliferation and drug resistanceOncol Lett20171331899190428454341
- ShengWDongMChenCCooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancerFASEB J20173162429243828223335
- JiaoYSunYTangXRenQYangWTumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic DrugsSmall201511161962197425504837
- Kramer-MarekGGoreJKorcMMolecular imaging in pancreatic cancer – a roadmap for therapeutic decisionsCancer Lett2013341213213823941833
- PolasekMYangYSchühleDTMolecular MR imaging of fibrosis in a mouse model of pancreatic cancerSci Rep201771811428808290
- WangYLiuYLuehmannHEvaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imagingACS Nano2012675880588822690722
- SzymanskiPMahmoudMAO’NeilDGarlyyevBEl-SayedMAElectronic and vibrational dynamics of hollow au nanocages embedded in cu2 o shellsPhotochem Photobiol201591359960625682692
- ZhuDMXieWXiaoYSErythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapyNanotechnology201829808400229339567
- PangBYangXXiaYPutting gold nanocages to work for optical imaging, controlled release and cancer theranosticsNanomedicine (Lond)201611131715172827348546
- ImanparastABakhshizadehMSalekRSazgarniaAPegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cellsPhotodiagnosis Photodyn Ther20182329530530048763
- ChoNHanWHanBKBreast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation TherapyJAMA Oncol20173111495150228655029
- DengLKeXHeZA MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancerInt J Nanomedicine201275053506523028227
- WangLAnYYuanCGEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cellsInt J Nanomedicine2015102507251925848268
- JaidevLRChellappanDRBhavsarDVMulti-functional nanoparticles as theranostic agents for the treatment & imaging of pancreatic cancerActa Biomater20174942243327890622
- LiCDuXTaiSGPC1 regulated by miR-96-5p, rather than miR-182-5p, in inhibition of pancreatic carcinoma cell proliferationInt J Mol Sci20141546314632724736782
- DiamandisEPPlebaniMGlypican-1 as a highly sensitive and specific pancreatic cancer biomarkerClin Chem Lab Med2016541e1e226389634
- Herreros-VillanuevaMBujandaLGlypican-1 in exosomes as biomarker for early detection of pancreatic cancerAnn Transl Med2016446427004211
- MeloSALueckeLBKahlertCGlypican-1 identifies cancer exosomes and detects early pancreatic cancerNature2015523755917718226106858
- GaoSTanHZhuNOridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cellsInt J Oncol20164862453246027082253
- YangIHShinJALeeKEKimJChoNPChoSDOridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AXEur J Oral Sci2017125643844329083074
- XiaSZhangXLiCGuanHOridonin inhibits breast cancer growth and metastasis through blocking the Notch signalingSaudi Pharm J201725463864328579904
- GuiZLuoFYangYShenCLiSXuJOridonin inhibition and miR200b3p/ZEB1 axis in human pancreatic cancerInt J Oncol201750111112027878247
- DingCZhangYChenHNovel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubilityJ Med Chem201356125048505823746196
- BothraSBabuLTPairaPAshok KumarSKKumarRSahooSKA biomimetic approach to conjugate vitamin B6 cofactor with the lysozyme cocooned fluorescent AuNCs and its application in turn-on sensing of zinc(II) in environmental and biological samplesAnal Bioanal Chem2018410120121029098339
- YanHSongJJiaXZhangZHyaluronic acid-modified didecyldimethylammonium bromide/d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluationDrug Deliv2017241303928155337
- JinYMaXFengSHyaluronic Acid Modified Tantalum Oxide Nanoparticles Conjugating Doxorubicin for Targeted Cancer TheranosticsBioconjug Chem201526122530254126554699
- LiuHNGuoNNWangTTMitochondrial Targeted Doxorubicin- Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo StudiesMol Pharm201815388289129357260
- YouQSunQYuMBSA-Bioinspired Gadolinium Hybrid- Functionalized Hollow Gold Nanoshells for NIRF/PA/CT/MR Quad- modal Diagnostic Imaging-Guided Photothermal/Photodynamic Cancer TherapyACS Appl Mater Interfaces2017946400174003029087183
- AgrahariVMengJEzoulinMJStimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activityNanomedicine201611222935295827785967
- LuoYWangXDuDLinYHyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug deliveryBiomater Sci20153101386139426301700
- GhorbaniMBigdeliBJalili-BalehLCurcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold-iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranosticsEur J Pharm Sci201811417518829248558
- LiuYShiQFQiMTashiroSOnoderaSIkejimaTInterruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer A549 cells via c-met-nuclear factor-κB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathwaysBiol Pharm Bull20123571150115822791165
- SunZHanQDuanLYuanQWangHOridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cellsOncol Lett20181521999200529434900
- LwinTMMurakamiTMiyakeKTumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared FluorophoreAnn Surg Oncol20182541079108529372363
- MohammadJDhillonHChikaraSPiperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer modelsOncotarget2018912104571046929535819
- DouYLiXYangWPB@Au Core-Satellite Multifunctional Nanotheranostics for Magnetic Resonance and Computed Tomography Imaging in Vivo and Synergetic Photothermal and Radiosensitive TherapyACS Appl Mater Interfaces2017921263127228029033
- MuthuMSKuttyRVLuoZXieJFengSSTheranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclustersBiomaterials20153923424825468374
- KulttiAZhaoCSinghaNCAccumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironmentBiomed Res Int2014201481761325147816
- HanHWangJChenTYinLJinQJiJEnzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatmentJ Colloid Interface Sci201750721722428800445
- ZhouHQianWUckunFMIGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerACS Nano2015987976799126242412
- AghevlianSLuYWinnikMAHedleyDWReillyRMPanitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to (111) In and (177) Lu-An EGFR-Targeted Theranostic for Pancreatic CancerMol Pharm20181531150115929314858
- JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
- WongRMGilbertDALiuKLouieAYRapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticlesACS Nano2012643461346722417124
- ChaoYKarmaliPPMukthavaramRDirect recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AIACS Nano2013754289429823614696
- Pelegri-O’DayEMLinEWMaynardHDTherapeutic protein-polymer conjugates: advancing beyond PEGylationJ Am Chem Soc201413641143231433225216406
- JaqueDMartínez MaestroLdel RosalBNanoparticles for photothermal therapiesNanoscale20146169494953025030381
- PerraultSDWalkeyCJenningsTFischerHCChanWCMediating tumor targeting efficiency of nanoparticles through designNano Lett2009951909191519344179
- LiuFLeWMeiTIn vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with antimesothelin antibodyInt J Nanomedicine2016112195220727274243
- FanKCaoCPanYMagnetoferritin nanoparticles for targeting and visualizing tumour tissuesNat Nanotechnol20127745946422706697
- ChenWHXuXDJiaHZTherapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivoBiomaterials201334348798880723932289
- HernandezRHeskampSRijpkemaMPreventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging AgentsTheranostics2017711828042311
- Villanueva-MeyerJEWoodMDChoiBSMRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and PrognosisAJR Am J Roentgenol2018210362162829261348
- YuJJLeeHAKimJHBio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicinJ Drug Target200715427928417487696
- WangGGaoWZhangXMeiXAu Nanocage Functionalized with Ultra-small Fe3O4 Nanoparticles for Targeting T1-T2Dual MRI and CT Imaging of TumorSci Rep201662825827312564